efavirenz/emtricitabine/tenofovir disoproxil zentiva
zentiva k.s. - efavirenz, emtricitabine, tenofovir disoproxil, phosphate - hiv infections - antivirals for systemic use, - efavirenz/emtricitabine/tenofovir disoproxil zentiva is a fixed-dose combination of efavirenz, emtricitabine and tenofovir disoproxil. it is indicated for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adults aged 18 years and over with virologic suppression to hiv-1 rna levels of < 50 copies/ml on their current combination antiretroviral therapy for more than three months. patients must not have experienced virological failure on any prior antiretroviral therapy and must be known not to have harboured virus strains with mutations conferring significant resistance to any of the three components contained in efavirenz/emtricitabine/tenofovir disoproxil zentiva prior to initiation of their first antiretroviral treatment regimen., the demonstration of the benefit of the combination efavirenz/emtricitabine/tenofovir disoproxil is primarily based on 48-week data from a clinical study in which patients with stable virologic suppression on a combination antiretroviral therapy changed to efavir
efedrin unimedic 5 mg/ml injektionsvätska, lösning
noradrenaline concentrate for solution for infusion
kalceks jsc - noradrenaline (noradrenaline tartrate) - concentrate for solution for infusion - 1mg/ml
noradrenaline concentrate for solution for infusion
kalceks jsc - noradrenaline tartrate - concentrate for solution for infusion - 1mg/ml
noradrenaline concentrate for solution for infusion
kalceks jsc - noradrenaline tartrate - concentrate for solution for infusion - 1mg/ml
xylonor especial 2% 50 cartutxos 1,8 ml
oraverse 400 mikrogramm/1,7 ml injektionslösung
labetalol s.a.l.f. 5 mg/ml injektions-/infusionsvätska, lösning
atomoxetin medical valley 25 mg kapsel, hård
atomoxetin medical valley 40 mg kapsel, hård